Since 2024: Glaring Reality Keeps AbbVie on Hold
AbbVie’s stock has climbed since 2024, yet a stubborn balance sheet and looming biosimilar erosion create a cautious ...
Curious about what you can buy with credit card points? Explore a variety of exciting options to make the most of your rewards!
28,188 articlesAbbVie’s stock has climbed since 2024, yet a stubborn balance sheet and looming biosimilar erosion create a cautious ...
Jim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
A new AI-focused ETF from Wedbush-backed manager Dan Ives is drawing attention for its blend of megacap AI leaders an...
A cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
Citi issued a life sciences sector note that elevates Agilent Technologies while reducing Icon PLC’s target, signalin...
The June S&P 500 quarterly rebalance could see new entrants like Marvell Technology, Reddit, and a mortgage-focused s...
Coherent is set to join the S&P 500 on March 23, 2026, triggering automatic purchases by index funds. The move follow...
A high-stakes summer clash for American attention pits the NBA Finals against the USMNT World Cup debut on home soil,...
This analysis breaks down the Q4 2025 earnings transcript for quest resource (qrhc), highlighting revenue, margins, a...
Private equity takes the helm at Pizza Hut in a $2.7 billion split deal, redefining a 1950s-era brand for the modern ...
A veteran executive coach shows how Beat the Plan helps Fortune 500 leaders cut decision time, improve quality, and s...
SpaceX’s market cap vaults above $3 trillion, turning a $60 billion Cursor acquisition into a relative rounding error...